Lymphofollicular HyperplasiaSymptoms, Doctors, Treatments, Advances & More
Learn About Lymphofollicular Hyperplasia
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Ballad Health Medical Associates Sleep Medicine
Celso Ebeo is a Pulmonary Medicine provider practicing medicine in Greeneville, Tennessee. Dr. Ebeo is rated as a Distinguished provider by MediFind in the treatment of Lymphofollicular Hyperplasia. He is also highly rated in 50 other conditions, according to our data. His clinical expertise encompasses Obstructive Sleep Apnea, Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Pneumonia, and Advanced Bronchoscopy. Dr. Ebeo is board certified in American Board Of Internal Medicine.
SOFHA Pulmonology
Maria Garcia is a Pulmonary Medicine provider practicing medicine in Johnson City, Tennessee. Dr. Garcia is rated as a Distinguished provider by MediFind in the treatment of Lymphofollicular Hyperplasia. She is also highly rated in 47 other conditions, according to our data. Her clinical expertise encompasses Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Asthma in Children, Lung Nodules, and Advanced Bronchoscopy. Dr. Garcia is board certified in American Board Of Internal Medicine.
UT MD Anderson Cancer Center
Horiana Grosu is an Intensive Care Medicine provider practicing medicine in Houston, Texas. Dr. Grosu is rated as an Elite provider by MediFind in the treatment of Lymphofollicular Hyperplasia. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Pleural Effusion, Lymphofollicular Hyperplasia, Lung Cancer, Endoscopy, and Advanced Bronchoscopy.
Summary: The advent of PSMA-PET has improved sensitivity and specificity in staging prostate cancer, particularly in intermediate- and high-risk disease. This has created uncertainty in the management of patients with PSMA-positive but conventionally negative pelvic lymphadenopathy (i.e., \<1 cm in smallest diameter). This study evaluates outcomes of enhanced androgen deprivation therapy (ADT) with abirate...
Summary: This phase I trial studies the best dose and side effects of the VSV-hIFNβ-NIS vaccine with or without cyclophosphamide and combinations of ipilimumab, nivolumab, and cemiplimab in treating patients with multiple myeloma, acute myeloid leukemia or lymphoma that has come back after a period of improvement (relapsed) or that does not respond to treatment (refractory). VSV-IFNβ-NIS is a modified vers...